Senior Attorney: NAD Fills Regulatory “Void” In Setting Ad Standards
This article was originally published in The Rose Sheet
NAD decisions reference FDA and Federal Trade Commission regulations, but go a distance on their own to establish standards for advertising claims, senior attorney Kathleen Dunnigan suggests. “What we really do is we fill a void, which is to set advertising standards and to try to get truthful and accurate claims,” she says at FDLI’s annual conference.
You may also be interested in...
Using marketing claims that overstep cosmetic boundaries can land firms in class-action suits that sap resources and drag on for years in today’s litigious climate, attorneys noted at the ACI Legal, Regulatory and Compliance Forum on Cosmetics in New York. Speakers provided examples and tips for staying out of court.
In a challenge brought by Coppertone sunscreen products marketer Merck & Co., NAD reviews claims for Neutrogena in print, online and in-store advertising, as well as on packaging for Neutrogena Beach Defense lotion and spray. J&J argues its claim uses same term as FDA’s online “Sun Protection” page.
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.